NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells

J Cell Sci. 2006 Jul 15;119(Pt 14):2985-94. doi: 10.1242/jcs.03014. Epub 2006 Jun 27.

Abstract

NFAT family is recognized as a transcription factor for inflammation regulation by inducing the expression of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), the key mediator of inflammation, which was reported to induce cell transformation in mouse epidermal Cl41 cells. In this study, we demonstrated that TNF-alpha was able to induce NFAT activation, as well as the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). The induction of COX-2 by TNF-alpha was abolished by knockdown of NFAT3 with its siRNA, while the induction of iNOS was not effected. Moreover, TNF-alpha-induced anchorage-independent cell growth was significantly inhibited by NFAT3 siRNA and cyclosporine A, a chemical inhibitor for the calcineurin/NFAT pathway, which suggests the importance of NFAT3 in regulating TNF-alpha-induced anchorage-independent cell growth. Consequently, impairment of COX-2 by its siRNA or selective inhibitor also inhibited TNF-alpha-induced anchorage-independent cell growth. Taken together, our results indicate that NFAT3 plays an important role in the regulation of TNF-alpha-induced anchorage-independent cell growth, at least partially, by inducing COX-2 expression in Cl41 cells. These findings suggest that NFAT3/cyclooxygenase-2 act as a link between inflammation and carcinogenesis by being involved in the tumor promotion stage.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Line
  • Cell Transformation, Neoplastic / drug effects*
  • Cyclooxygenase 2 / biosynthesis*
  • Enzyme Induction / drug effects
  • Epidermal Cells*
  • Epidermis / drug effects*
  • Epidermis / enzymology
  • Gene Expression Regulation, Enzymologic / drug effects*
  • Humans
  • Mice
  • NFATC Transcription Factors / metabolism*
  • Nitric Oxide Synthase Type II / biosynthesis
  • Promoter Regions, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • NFATC Transcription Factors
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2